Abiopharma

Clinical trial NCT07621003: start date: 2026-07-01 → 2026-08-17.

Clinical trial NCT06139211 updates: 1. status: RECRUITING → COMPLETED 2. start date: 2024-01-03 → 2023-12-06 3. completion date: 2026-01-28 → 2026-05-28 4. primary completion date: 2025-11-01 → 2026-05-28 5. enrollment: 186 → 66 participants 6. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07556588: start date: 2026-04-15 → 2024-08-03.

Clinical trial NCT07681271: enrollment: 80 → 100 participants.

Clinical trial NCT07538544: start date: 2026-07-01 → 2026-09-15.

Clinical trial NCT07324200 updates: 1. status: RECRUITING → COMPLETED 2. enrollment: 80 → 71 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07037771 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 60 → 70 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06922695 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-04-15 → 2027-07-31 3. primary completion date: 2027-04-15 → 2027-04-30

Clinical trial NCT04665037 updates: 1. completion date: 2026-12-31 → 2027-04-15 2. primary completion date: 2026-12-16 → 2027-03-31

Clinical trial NCT05040087 updates: 1. completion date: 2027-12-31 → 2028-06-30 2. primary completion date: 2027-04-30 → 2026-12-31